- Type / Class
- Equity / ADR
- Shares outstanding
- 50,698,400
- Total 13F shares
- 21,039,614
- Share change
- +1,299,334
- Total reported value
- $784,510,369
- Put/Call ratio
- 169%
- Price per share
- $37.31
- Number of holders
- 66
- Value change
- +$56,584,747
- Number of buys
- 29
- Number of sells
- 23
Quarterly Holders Quick Answers
What is CUSIP 45258D105?
CUSIP 45258D105 identifies IMCR - Immunocore Holdings plc - ADR in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258D105:
Top shareholders of IMCR - Immunocore Holdings plc - ADR (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rock Springs Capital Management LP |
13F
|
Company |
5%
|
2,552,034
|
$76,306,000 | — | 31 Mar 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5%
|
2,520,730
|
$75,370,000 | — | 31 Mar 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.7%
|
1,859,471
|
$55,598,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
3.2%
|
1,627,555
|
$48,664,000 | — | 31 Mar 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
2.7%
|
1,363,800
|
$40,778,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.6%
|
1,342,359
|
$40,136,000 | — | 31 Mar 2022 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
1.9%
|
950,000
|
$28,405,000 | — | 31 Mar 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
1.6%
|
808,549
|
$24,175,000 | — | 31 Mar 2022 | |
| Gates Foundation |
13F
|
Company |
1.1%
|
576,923
|
$17,200,000 | — | 31 Mar 2022 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.98%
|
499,190
|
$14,926,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.98%
|
496,182
|
$14,836,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.8%
|
407,058
|
$12,171,000 | — | 31 Mar 2022 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.76%
|
387,694
|
$11,592,000 | — | 31 Mar 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
385,600
|
$11,529,000 | — | 31 Mar 2022 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.75%
|
380,811
|
$11,386,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.68%
|
343,279
|
$10,264,000 | — | 31 Mar 2022 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.68%
|
342,478
|
$10,240,000 | — | 31 Mar 2022 | |
| Bain Capital Public Equity Management II, LLC |
13F
|
Company |
0.63%
|
317,676
|
$9,499,000 | — | 31 Mar 2022 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.58%
|
293,385
|
$8,772,000 | — | 31 Mar 2022 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.55%
|
280,361
|
$8,327,000 | — | 31 Mar 2022 | |
| Pier Capital, LLC |
13F
|
Company |
0.47%
|
236,616
|
$7,075,000 | — | 31 Mar 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.46%
|
235,545
|
$7,043,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.39%
|
200,000
|
$5,980,000 | — | 31 Mar 2022 | |
| Rathbones Group PLC |
13F
|
Company |
0.37%
|
190,015
|
$5,681,000 | — | 31 Mar 2022 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.36%
|
180,000
|
$5,382,000 | — | 31 Mar 2022 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.34%
|
170,472
|
$5,097,000 | — | 31 Mar 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.32%
|
160,963
|
$4,813,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.25%
|
128,100
|
$3,830,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
59,726
|
$1,786,000 | — | 31 Mar 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.11%
|
53,878
|
$1,611,000 | — | 31 Mar 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
52,174
|
$1,560,000 | — | 31 Mar 2022 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.1%
|
51,535
|
$1,541,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.09%
|
44,226
|
$1,322,000 | — | 31 Mar 2022 | |
| Waverton Investment Management Ltd |
13F
|
Company |
0.07%
|
37,330
|
$1,116,000 | — | 31 Mar 2022 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.07%
|
36,811
|
$1,101,000 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
27,506
|
$822,000 | — | 31 Mar 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.05%
|
24,120
|
$721,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.04%
|
22,369
|
$667,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.04%
|
21,793
|
$647,252 | — | 31 Mar 2022 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.03%
|
13,534
|
$402,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
9,475
|
$283,000 | — | 31 Mar 2022 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
8,186
|
$267,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
8,408
|
$251,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
7,300
|
$218,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,832
|
$204,000 | — | 31 Mar 2022 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
5,216
|
$156,000 | — | 31 Mar 2022 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.01%
|
3,864
|
$116,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,658
|
$79,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,352
|
$70,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,108
|
$33,000 | — | 31 Mar 2022 |
Institutional Holders of Immunocore Holdings plc - ADR (IMCR) as of Q2 2022
As of 30 Jun 2022,
Immunocore Holdings plc - ADR (IMCR) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,039,614 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, FMR LLC, Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, GENERAL ATLANTIC, L.P., FIRST MANHATTAN CO, Paradigm Biocapital Advisors LP, and Bill & Melinda Gates Foundation.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
57
Q2 2022 holders
66
Holder diff
9
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.